A. M. L. Lever

1.8k total citations
30 papers, 1.5k citations indexed

About

A. M. L. Lever is a scholar working on Immunology, Virology and Infectious Diseases. According to data from OpenAlex, A. M. L. Lever has authored 30 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 9 papers in Virology and 8 papers in Infectious Diseases. Recurrent topics in A. M. L. Lever's work include HIV Research and Treatment (9 papers), HIV/AIDS drug development and treatment (6 papers) and T-cell and Retrovirus Studies (5 papers). A. M. L. Lever is often cited by papers focused on HIV Research and Treatment (9 papers), HIV/AIDS drug development and treatment (6 papers) and T-cell and Retrovirus Studies (5 papers). A. M. L. Lever collaborates with scholars based in United Kingdom, United States and Australia. A. M. L. Lever's co-authors include Joseph Sodroski, William A. Haseltine, Heinrich G. Göttlinger, Emma Terwilliger, Dana Gabuzda, J. F. Kaye, Andy Muir, Ashley Moffett, Andrew J. Edwards and J. Farrant and has published in prestigious journals such as Journal of Virology, Journal of Hepatology and Annals of the Rheumatic Diseases.

In The Last Decade

A. M. L. Lever

30 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. M. L. Lever United Kingdom 18 730 674 387 338 289 30 1.5k
J W Dubay United States 13 615 0.8× 1.1k 1.6× 334 0.9× 629 1.9× 228 0.8× 18 1.7k
Douglas Braaten United States 16 1.1k 1.4× 1.0k 1.5× 538 1.4× 501 1.5× 171 0.6× 21 1.8k
Jerry L. Blackwell United States 20 650 0.9× 449 0.7× 425 1.1× 466 1.4× 638 2.2× 36 1.8k
Jane Mirro United States 18 632 0.9× 864 1.3× 215 0.6× 376 1.1× 273 0.9× 20 1.3k
Martin Heinkelein Germany 24 609 0.8× 705 1.0× 213 0.6× 370 1.1× 846 2.9× 36 1.6k
Melissa Kane United States 13 493 0.7× 530 0.8× 678 1.8× 506 1.5× 161 0.6× 22 1.5k
Fadila Bouamr United States 23 786 1.1× 947 1.4× 461 1.2× 507 1.5× 192 0.7× 38 1.8k
Jianbo Chen United States 24 807 1.1× 951 1.4× 276 0.7× 640 1.9× 176 0.6× 41 2.0k
Joost Haasnoot Netherlands 20 1.3k 1.8× 265 0.4× 242 0.6× 266 0.8× 295 1.0× 22 1.7k
Lily I. Wu United States 18 953 1.3× 1.2k 1.8× 650 1.7× 632 1.9× 276 1.0× 21 2.0k

Countries citing papers authored by A. M. L. Lever

Since Specialization
Citations

This map shows the geographic impact of A. M. L. Lever's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. M. L. Lever with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. M. L. Lever more than expected).

Fields of papers citing papers by A. M. L. Lever

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. M. L. Lever. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. M. L. Lever. The network helps show where A. M. L. Lever may publish in the future.

Co-authorship network of co-authors of A. M. L. Lever

This figure shows the co-authorship network connecting the top 25 collaborators of A. M. L. Lever. A scholar is included among the top collaborators of A. M. L. Lever based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. M. L. Lever. A. M. L. Lever is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kenyon, Julia C. & A. M. L. Lever. (2011). XMRV, prostate cancer and chronic fatigue syndrome. British Medical Bulletin. 98(1). 61–74. 6 indexed citations
2.
Farrington, M., T. G. Wreghitt, A. M. L. Lever, et al.. (2006). Neural Transplantation in Huntington's Disease: The NEST-UK Donor Tissue Microbiological Screening Program and Review of the Literature. Cell Transplantation. 15(4). 279–294. 11 indexed citations
3.
Muir, Andy, A. M. L. Lever, & Ashley Moffett. (2006). Human endogenous retrovirus-W envelope (syncytin) is expressed in both villous and extravillous trophoblast populations. Journal of General Virology. 87(7). 2067–2071. 45 indexed citations
4.
Muir, Andy, A. M. L. Lever, & Ashley Moffett. (2004). Expression and Functions of Human Endogenous Retroviruses in the Placenta: An Update. Placenta. 25. S16–S25. 55 indexed citations
5.
Richardson, Jennifer, et al.. (2001). Chromosomal positioning of human T-lymphotropic type 1 proviruses by fluorescence in situ hybridisation. Journal of Virological Methods. 93(1-2). 65–74. 5 indexed citations
6.
Nelson, Paul N., A. M. L. Lever, Robert J. Smith, et al.. (1999). Molecular Investigations Implicate Human Endogenous Retroviruses as Mediators of Anti-Retroviral Antibodies in Autoimmune Rheumatic Disease. Immunological Investigations. 28(4). 277–289. 43 indexed citations
7.
Lever, A. M. L., et al.. (1999). Lentivirus vectors for gene therapy. Biochemical Society Transactions. 27(6). 841–847. 9 indexed citations
8.
Mendelson, George, et al.. (1998). Development of autoantibodies and factor VIII inhibitor in an HIV-infected haemophiliac following treatment with combination anti-retroviral therapy.. PubMed. 102(5). 1382–3. 5 indexed citations
9.
Greatorex, Jane & A. M. L. Lever. (1998). Retroviral RNA dimer linkage.. Journal of General Virology. 79(12). 2877–2882. 45 indexed citations
10.
Lever, A. M. L., et al.. (1998). Development of cell lines stably expressing human immunodeficiency virus type 1 proteins for studies in encapsidation and gene transfer.. Journal of General Virology. 79(2). 231–237. 11 indexed citations
11.
Lever, A. M. L.. (1996). The molecular biology of HIV/AIDS. 9 indexed citations
12.
Miele, Gino, Andrew J. Mouland, G P Harrison, Éric A. Cohen, & A. M. L. Lever. (1996). The human immunodeficiency virus type 1 5' packaging signal structure affects translation but does not function as an internal ribosome entry site structure. Journal of Virology. 70(2). 944–951. 85 indexed citations
13.
Harrison, G P, Elizabeth Hunter, & A. M. L. Lever. (1995). Secondary structure model of the Mason-Pfizer monkey virus 5' leader sequence: identification of a structural motif common to a variety of retroviruses. Journal of Virology. 69(4). 2175–2186. 37 indexed citations
14.
Nelson, Paul N., A. M. L. Lever, F E Bruckner, et al.. (1994). Polymerase chain reaction fails to incriminate exogenous retroviruses HTLV-I and HIV-1 in rheumatological diseases although a minority of sera cross react with retroviral antigens.. Annals of the Rheumatic Diseases. 53(11). 749–754. 25 indexed citations
15.
Gabuzda, Dana, A. M. L. Lever, Emma Terwilliger, & Joseph Sodroski. (1992). Effects of deletions in the cytoplasmic domain on biological functions of human immunodeficiency virus type 1 envelope glycoproteins. Journal of Virology. 66(6). 3306–3315. 164 indexed citations
16.
Lever, A. M. L., et al.. (1987). Increased half-life of gammaglobulin after prolonged intravenous replacement therapy.. PubMed. 67(2). 441–6. 7 indexed citations
17.
Scully, Linda, A. M. L. Lever, I. Yap, Massimo Pignatelli, & Howard C. Thomas. (1986). Identification of factors influencing response rate to antiviral therapy of chronic hepatitis B virus infection. Journal of Hepatology. 3. S291–S299. 12 indexed citations
18.
Lever, A. M. L., et al.. (1986). Has immunology become important to hepatologists?. PubMed. 8. 179–89. 8 indexed citations
19.
Lever, A. M. L., Jean M. Dolby, Anthony Webster, & A B Price. (1984). Chronic campylobacter colitis and uveitis in patient with hypogammaglobulinaemia.. BMJ. 288(6416). 531.1–531. 17 indexed citations
20.
Lever, A. M. L., et al.. (1983). INCREASED SERUM CONCENTRATION OF T4‐BINDING GLOBULIN IN PATIENTS WITH HYPOGAMMAGLOBULINAEMIA. Clinical Endocrinology. 18(2). 195–199. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026